GSE176008 pyridoxine 0 v 1 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE176008_pyridoxine_0_v_1_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE176008_pyridoxine_0_v_1_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE176008_pyridoxine_0_v_1_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE176008_pyridoxine_0_v_1_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

Rho GTPase activating protein 23

Gene

family with sequence similarity 106 member A

Gene

Pvt1 oncogene

Gene

CROCC pseudogene 2

Gene

Gfo/Idh/MocA-like oxidoreductase domain containing 3, pseudogene

Gene

long intergenic non-protein coding RNA 641

Gene

long intergenic non-protein coding RNA 1128

Gene

tripartite motif containing 15

Gene

DPY19L2 pseudogene 2

Gene

WASP family homolog 5, pseudogene

  • Gene

    Rho GTPase activating protein 23


  • Gene

    family with sequence similarity 106 member A



  • Gene

    CROCC pseudogene 2


  • Gene

    Gfo/Idh/MocA-like oxidoreductase domain containing 3, pseudogene


  • Gene

    long intergenic non-protein coding RNA 641


  • Gene

    long intergenic non-protein coding RNA 1128


  • Gene

    tripartite motif containing 15


  • Gene

    DPY19L2 pseudogene 2


  • Gene

    WASP family homolog 5, pseudogene

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.